International Companies

Novo Nordisk cuts guidance but says generic competition will ease

By Benjamin Chiou

Date: Wednesday 07 May 2025

(Sharecast News) - Novo Nordisk's stock was rising strongly on Wednesday after the Danish drugmaker beat profit forecasts in the first quarter, as investors shrugged off a sales miss and a downgrade to full-year guidance.
Net profits jumped 14% to DKK29.0bn, beating the DKK27.8bn market estimate, causing shares to jump 5%...

Sign up for free or to read the full story

Email this article to a friend

or share it with one of these popular networks:


Article Archive

Top of Page